AMT (Alpha-Methyltryptamine) – Scientific Product Description

Almennar upplýsingar

Substance Name:  Alfa-metýltryptamín (AMT)
Efnaflokkur:  Tryptamine derivative
Staða:  Research chemical
Skammtar:  Varies (10-50mg for research purposes)
Eyðublað:  Powder or pellets (depending on availability)

Lyfjafræðilegir eiginleikar

AMT is a monoamine alkaloid with a unique mechanism of action that both:

• Serotonergic  (5-HT₂A agonism)

• Dopaminergic  (dopamine reuptake inhibition)

• Exhibits noradrenergic  effects

Möguleg rannsóknarsvið

1. Neuropsychological Examination

• Influence on perceptual processing

• Modulation of cognitive flexibility

• Effects on creative thinking

2. Behavioral Science Studies

• Social interaction patterns

• Emotional processing mechanisms

• Motivation and reward systems

3. Theoretical Applications

• Possible antidepressant effects (preclinical study)

• Impact on sleep architecture

• Neuroplastic changes

Dosage & Protocol

Research dose range:

• Lágur skammtur:  10-20 mg

• Meðalskammtur:  20-35 mg

• Stór skammtur:  35-50 mg

Time lapse:

• Onset of effects: 45-90 minutes

• Peak performance: 3-5 hours

• Total duration: 8-12 hours

Safety aspects

Aukaverkanir

• Increased body temperature

• Hraðsláttur

• Ljósopens

• Possible gastrointestinal discomfort

Contraindications

• Samsetning með MAO-hemlum

• Cardiovascular diseases

• Psychiatric history

Rannsóknarstofugreining

Hreinleiki:  ≥97% (HPLC)
Stöðugleiki:  Geymið á köldum, þurrum stað (<25°C)
Óhreinindi:  <0.5% (GC-MS analysis)

Lögleg staða

Holland:  Opium Act Schedule I
Belgium:  Prohibited substance
ESB:  Under EU NPS legislation

Research protocols

1. Start low:  10mg initial test dose

2. Pharmaceutical monitoring:  Blood pressure and temperature measurement

3. Intervals:  Minimum 7 days between experiments

Mikilvægar viðvaranir

❌ Engin manneldisneysla
❌ Do not combine with other psychoactives
❌ Avoid prolonged or frequent use

This product is intended solely for in vitro research og scientific study under controlled laboratory conditions.

1cP-LSD 150 MCG listabletti O-DSMT 50 mg kúlur 1V-LSD 150 MCG þynnur 6-CL-ADBA